EKSO - Ekso Bionics Holdings, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 561.15M
Enterprise Value 354.15M
Trailing P/E N/A
Forward P/E 1-2.72
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4.81
Price/Book (mrq)11.34
Enterprise Value/Revenue 34.26
Enterprise Value/EBITDA 6-2.95

Trading Information

Stock Price History

Beta (3Y Monthly) 2.33
52-Week Change 3-67.19%
S&P500 52-Week Change 31.73%
52 Week High 32.8100
52 Week Low 30.7700
50-Day Moving Average 31.0689
200-Day Moving Average 31.7458

Share Statistics

Avg Vol (3 month) 3374.83k
Avg Vol (10 day) 3278.96k
Shares Outstanding 560.83M
Float 53.25M
% Held by Insiders 11.68%
% Held by Institutions 138.51%
Shares Short (Jul 31, 2019) 42.57M
Short Ratio (Jul 31, 2019) 49.56
Short % of Float (Jul 31, 2019) 45.50%
Short % of Shares Outstanding (Jul 31, 2019) 43.43%
Shares Short (prior month Jun 28, 2019) 42.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 27/1
Last Split Date 3May 5, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -162.94%
Operating Margin (ttm)-152.96%

Management Effectiveness

Return on Assets (ttm)-49.86%
Return on Equity (ttm)-318.22%

Income Statement

Revenue (ttm)12.72M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)9.90%
Gross Profit (ttm)4.31M
EBITDA -18.34M
Net Income Avi to Common (ttm)-20.73M
Diluted EPS (ttm)-0.3190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.26M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)5.23M
Total Debt/Equity (mrq)96.85
Current Ratio (mrq)2.37
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-19.07M
Levered Free Cash Flow (ttm)-10.53M